Drugs to Treat CHF Flashcards

(92 cards)

1
Q

CHF occurs when

A

the heart is unable to pump enough oxygenated blood to meet the demands of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The heart is failing when

A

cardiac output is insufficient to meet the needs of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CO is mainly affected by which two factors:

A

stroke volume and heart rate, each of which are affected by different factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiovascular consequences of decreased CO

A

tachycardia; cardiomeglia; arrhythmias; fatigue/exercise intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Respiratory consequences of decreased cardiac output (CO)

A

shortness of breath; pulmonary edema; cyanosis; orthopnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Preload is the

A

left ventricular end diastolic pressure or volume, meaning the amount of stretch on the heart at the end of diastole before contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Afterload is the

A

force that the ventricle has to push against to eject blood during systole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Frank-Starling Relationship

A

input-output relationship of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why can the heart respond with greater stroke volume when it is stretched more?

A

Stretching the heart (sarcomeres in the myocytes) results in the myocyte responding with greater force of contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does the heart contract more forcefully with more stretch?

A

actin and myosin become aligned better when the sarcomeres are stretched, with a maximum force being generated when sarcomeres are 2 to 2.2 microns in length

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens when the sarcomeres are stretched ore tha 2 to 2.2 microns?

A

the actin and myosin are not aligned properly and force cannot be further increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contractility is

A

the force with which the heart contracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens to stoke volume in conditions that increase inotropy (contractility)

A

stroke volume increases for a given LVEDV or preload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do optimized hearts look like on the Frank-Starling relationship curve?

A

optimized hearts have a steeper curve, where small changes in preload (LV end diastolic volume) results in large increases in stroke volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do failing hearts look like on the Frank-Starling relationship curve?

A

Failing hearts do not respond well to increased preload, and a CHF patient will often exhibit a flatter curve resembling the red one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are afterload and SV related?

A

inversely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Failing hearts start to show signs of being sensitive to what?

A

of being “sensitive” to afterload, with severe cases of heart failure being very sensitive to increases in afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What increases stroke volume for a given value of afterload?

A

preload and inotropy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Compensation in CHF

A

compensation is when heart function is stable, though there is an underlying disease, and the patient is able to participate in many or more normal activities (though symptoms of CHF are present)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Decompensation in CHF

A

Decompensation is a period of time when the heart/CV system cannot compensate adequately for the reduced effectiveness of the CHF heart, and the person often experiences symptoms sufficient enough to put them in the hospital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Systolic heart failure

A

primarily a deficit in contraction; the heart muscle itself is weak and often dilated, making it unable to contract with sufficient strength to meet the needs of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Diastolic heart failure

A

primarily a deficit in relaxation; it may be strong enough to contract, but it can’t expand enough to allow blood to enter during diastole, resulting in reduced cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe progression of CHF

A

increased vascular resistance -> heart works harder and requires more oxygen ->hypoxia -> decreased functioning of the heart ->increased pre-load, pulmonary edema -> hypertrophic response (eventually exacerbates the problem)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Compensatory mechanisms in early heart failure

A
  1. sympathetic discharge
  2. RAAS activity
  3. cardiac remodeling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Compensatory mechanisms in early heart failure results in
increased SV but at a cost
26
What is afterload, SV and preload like in early heart failure
afterload is potentially high (hypertention); SV is reduced; preload stands to increase
27
What happens to the Starling curve in early HF
the patient starts to drop off the normal healthy Starling curve and begins to have a lowered curve
28
Increased sympathetic discharge can lead to
arrhythmias and remodeling via activation of beta Ars
29
Angiotensin II causes
vasoconstriction, stimulates remodeling, and induces aldosterone (which causes salt and water retention, increasing preload)
30
What does a CHF heart look like compared to a normal heart
CHF heart will have thicker ventricular walls and increased deposition of connective tissue
31
Increased connective tissue in a CHF heart is due to
myocyte cell death and replacement of these dead myocytes with fibroblasts
32
Calcium signals in cardiac myocytes contributes to
changes in gene expression as part of the hypertrophic remodeling response
33
What contributes to the increased expression of genes that mediate the hypertrophic remodeling response
when the heart cell goes through more rounds of calcium entry/exit (calcium cycling)
34
Patients with congestive heart failure can have their CHF exacerbated by what disease?
hyperthyroidism
35
What does it mean to say that patients are "afterload sensitive"
increases in afterload (basically blood pressure) bring about sharp reductions in stroke volume
36
What happens in late stage congestive heart failure
compensatory mechanisms can no longer adequately compensate for the problems; preload continues to increase; afterload increases; SV decreases; preload values in the "congestive range" where pulmonary function is compromised
37
Two main categories of drugs to treat CHF
1. Manipulate hemodynamics | 2. Inhibit compensation
38
Manipulate hemodynamics by
alleviating the extreme pressure problems of CHF and improve ability of the heart to function as a pump
39
Inhibit compensation by
using agents that seek to reverse the cardiac remodeling that occurs during CHF
40
ACE inhibitors address
both compensation as well as hemodynamics
41
What do vasodilators do?
dilate veins, lower preload and congestive symptoms
42
Vasodilators
organic nitrates, hydralazine
43
Diuretics
furosemide, bumetamide, and torsemide | decreases blood volume
44
Angiotensin inhibitors
ACE inhibitors, ATII rec. antagonists, renin inhibitors | decrease pressure and volume
45
Inotropic agents
digoxin, PDE3 inhibitors, beta-AR agonists | stimulate cardiac contractility
46
Inotropic agents for CHF
1. Cardiac glycosides 2. Phosphodiesterase inhibitors 3. beta-adrenergic agonists
47
Glycosides (digoxin) only used for
chronic therapy
48
PDE inhibitors and beta agonists are only used for
acutely decompensated patients, typically in hospital/ER settings
49
PDE inhibitors have a risk of inducing
arrhythmias long-term
50
What can beta agonists cause long term
desensitization
51
Role of calcium in cardiac myocyte contraction
Ca2+ enters through L-type channels and triggers further release of Ca2+ from internal stores via ryanodine receptors; Ca2+ must be removed from the myocyte before the next depolarization
52
How is Ca2+ removed from the myocyte
1. Ca2+ ATPase pumps Ca2+ out of the cell 2. SERCA pumps Ca2+ into the SR 3. NCX (Na+/Ca2+ exchange protein) extrudes Ca2+ in exchange for Na+
53
Key to NCX function
maintaining the sodium gradient outside/inside the cell (high Na+ outside and low Na+ inside)
54
partial blockade of the ATPase results in
increased release of Ca2+ into the cytoplasm during contraction and an increase in the strength of contraction
55
Overall, what does mild to moderate blockage of the sodium potassium ATPase do?
increases cardiac contractility by enhancing Ca2+ release during contraction
56
Specific effects of Na+/K+ ATPase blockade
increases [Na+]in which will decrease Ca2+ extrusion; more calcium is reloaded into intracellular stores; more Ca2+ is released in response to stimulation; muscle contracts with greater force
57
What does digoxin do?
``` increase cardiac contractility increase AV node refractoriness decrease heart rate decrease vascular sympathetic tone in CHF secondary to resensitization of baroreceptors vasodilation in CHF patients ```
58
Digoxin blocks
the sodium potassium ATPase
59
blocking the sodium potassium ATPase alters
the sodium gradient across the membrane, resulting in lower than normal sodium outside the cell and higher than normal sodium inside the cell
60
If you don't know the mechanism of action of digoxin go look at it
it's on page 26 and it's honestly really stupid; I don't feel like writing it out
61
Describe the structure of glycosides
all glycosides have a steroid nucleus; sugar moieties and lactone moieties define different classes of glycosides
62
Problems with glycosides
glycosides have a narrow therapeutic window; loading doses must be monitored closely (serum levels, EKG)
63
Common toxicities of glycosides
psychiatric: delirium, fatigue, malaise, confusion G.I.: anorexia, N&V, abdominal pain respiratory: increased response to hypoxia CV: pro-arrhythmic (atrial tachy, AV block)
64
Pharmacodynamics interactions of glycosides
1. beta-blockers and Ca2+ channel blockers: depress the heart, oppose digoxin action 2. Kaliuretic diuretics (increase K+ elimination): decrease K+, promoting digoxin action, raising risk for arrhythmias
65
beta-AR agonists
dobutamine, dopamine | prone to densensitization; cause hypertension
66
Phosphodiesterase 3 inhibitors
milrinone, amrinone | proarrhythmic; decreased survival
67
Inotropic agents for acute failure
beta-AR agonists | phosphodiesterase 3 inhibitors
68
CHF drugs: inhibiting compensation
1. Renin/angiotensin system inhibition 2. aldosterone antagonists 3. beta-AR blockers
69
Renin/angiotensin system inhibition
alleviates pressure and volume problems some stop/reverse remodeling first line treatment for CHF ACEi; ATII receptor antagonist, aliskiren
70
Aldosterone antagonists
decrease blood volume (diuretic-like) reverse/arrest hypertrophy spironolactone = aldosterone
71
beta-AR blockers
inhibit sympathetic overactivity in CHF decrease remodeling, reduce mortality carvedilol, metoprolol, bisoprolol
72
Spironolactone is used to block
the effects of aldosterone and inhibits angiotensin II's ability to increase preload
73
Pathophysiological effect of increased Na+ and water retention
edema, elevated cardiac filling pressures
74
Pathophysiological effect of K+ and Mg2+ loss
arrhythmogenesis and risk of sudden cardiac death
75
Pathophysiological effect of reduced myocardial NE uptake
potentiation of NE effects: myocardial remodeling and arrhythmogenesis
76
Pathophysiological effect of reduced baroreceptor sensitivity
reduced parasympathetic activity and risk of sudden cardiac death
77
Pathophysiological effect of myocardial fibrosis, fibroblast proliferation
remodeling and ventricular dysfunction
78
Pathophysiological effect of alterations in Na+ channel expression
increased excitability and contractility of cardiac myocytes
79
Beta blockers inhibit
the increased sympathetic drive in CHF, reducing the work of the heart, increasing time for filling in diastole, and prevention of remodeling
80
Common beta blockers in CHF
metoprolol bisoprolol carvedilol
81
afterload and preload with beta blockers
they decrease afterload though they might actually cause an increase in preload due to increased filling time during diastole
82
Angiotensin II stimulates ADH (vasopressin) secretion, resulting in
1. water retention 2. vasoconstriction 3. enhanced platelet aggregation 4. VSM and myocyte proliferation
83
Vasopressin receptor antagonists in CHF
Tolvaptan and Conivaptan
84
Adverse reactions of tolvaptan and conivaptan
hypotension, osmotic demyelination, CYP3A substrate
85
Tolvaptan and conivaptan used in
treatment of hyponatremia in HF and SIADH in acute care settings
86
What does neprilysin inhibition do?
increases levels of vasoactive peptides counters neurohumoral vasoconstriction, Na+ retention, and remodeling is investigation for CHF
87
What does neprilysin do?
neutral endopeptidase that degrades endogenous vasoactivate peptides (natriuretic peptides, bradykinin, adrenomedullin)
88
When do ventricles secrete natriuretic peptides (vasodilators)
in response to increased blood volume and stretch
89
Do inotropes improve preload problems?
No (only helps with the low output symptoms, not congestive symptoms)
90
ACE inhibitors reduce
both preload (via blood volume reduction) and afterload (via blood pressure reduction)
91
What would ACE inhibitors be expected to do with the Starling curve
might be expected to move a curve both upward out of the low-output range as well as leftward out of the congestive range
92
What do diuretics do to the Starling curve
they improve pulmonary edema by reducing blood volume but don't have much impact on stroke volume